Bradycardia Algorithm: Atropine, Pacing, Epinephrine

Bradycardia is one of those arrhythmias frequently encountered in clinical practice – and yet it regularly leads to uncertainty in acute management. Not every slow heart rate requires intervention. But when hemodynamic instability is imminent or already present, structured action following the ACLS bradycardia algorithm is essential. This article walks you through the algorithm step by step, examines pharmacological and electrical therapy options, and helps you confidently recognize the clinical decision points.

Definition and Clinical Relevance

Bradycardia is defined as a heart rate below 60 beats per minute. However, this threshold is merely a guideline – what matters is not the absolute number on the monitor, but the clinical impact on the patient. Trained endurance athletes frequently have resting heart rates around 40/min without any symptoms. Conversely, a heart rate of 55/min in a patient with severe aortic stenosis may already cause clinically significant hypoperfusion.

The ACLS bradycardia algorithm therefore defines a heart rate below 50/min as the therapeutically relevant threshold – but always in the context of clinical symptoms. The key question is not "How slow is the heart beating?" but rather "Is this rate causing symptoms or hemodynamic instability?"

Symptomatic vs. Asymptomatic Bradycardia

The distinction between symptomatic and asymptomatic bradycardia is the first and most important decision point in the algorithm.

Signs of Hemodynamic Instability

The following symptoms and findings indicate a symptomatic bradycardia requiring treatment:

• Hypotension (systolic blood pressure < 90 mmHg or clinically significant drop from baseline)
• Altered mental status (confusion, somnolence, syncope, presyncope)
• Signs of cardiogenic shock (cool, mottled extremities, prolonged capillary refill time)
• Acute heart failure (pulmonary edema, dyspnea, jugular venous distension)
• Anginal symptoms (as a sign of myocardial hypoperfusion due to low cardiac output)

Asymptomatic Bradycardia

If the patient is hemodynamically stable without any of the above signs, there is no indication for acute therapy. In this case: observe, monitor, investigate the cause – but do not escalate. This sounds trivial but is a common mistake in practice: A heart rate of 38/min on the monitor reflexively triggers reaching for atropine, even though the patient is alert, oriented, and hemodynamically stable with a blood pressure of 130/75 mmHg.

The ACLS Bradycardia Algorithm Step by Step

Step 1: Recognition and Initial Measures

As with every ACLS algorithm, management begins with systematic assessment:

1. Secure the airway – administer oxygen as needed, maintain airway patency
2. Establish monitoring – 12-lead ECG, pulse oximetry, blood pressure measurement, capnography if indicated
3. Establish intravenous access
4. Obtain and interpret a 12-lead ECG – identify the rhythm, recognize conduction abnormalities

The 12-lead ECG is essential because it allows you to classify the mechanism of the bradycardia – and thereby estimate the prognosis and likely response to atropine.

Step 2: Symptomatic or Not?

At this decision point, the algorithm diverges:

• No symptoms, hemodynamically stable → monitoring, observation, workup of the underlying cause. No acute therapy.
• Symptoms present or hemodynamic instability → proceed to Step 3.

Step 3: Atropine as First-Line Therapy

Atropine is the first-line medication for symptomatic bradycardia.

Dosing:

• 0.5 mg intravenous bolus
• If no effect: repeat every 3–5 minutes
• Maximum dose: 3 mg (equivalent to complete vagal blockade)

Important: Avoid doses below 0.5 mg! Paradoxically, very low atropine doses (e.g., 0.1–0.2 mg) can trigger paradoxical bradycardia by activating a central vagal reflex. Therefore, always administer at least 0.5 mg per single dose.

When Atropine Is Unlikely to Work

Atropine exerts its effect by blocking parasympathetic input at the sinus node and AV node. This means: in conduction blocks below the AV node (infranodal), an inadequate response should be expected.

Atropine is likely ineffective in:

• Second-degree AV block, Mobitz type 2 – infranodal block
• Third-degree AV block with wide QRS complex – the escape rhythm originates from the His-Purkinje system and is not vagally modulated
• Bradycardia after heart transplantation – the transplanted heart is denervated and does not respond to atropine

In these situations, do not waste valuable time with repeated atropine doses – escalate early to pacing or catecholamines.

Step 4: Escalation When Atropine Fails

If atropine is ineffective or the bradycardia is deemed atropine-refractory, three options are available – which can also be used in parallel:

1. Transcutaneous pacing
2. Epinephrine infusion
3. Dopamine infusion

Transcutaneous Pacing

Transcutaneous (external) pacing is the fastest and most reliable method for treating a refractory symptomatic bradycardia. It bridges the time until placement of a transvenous pacemaker.

Procedure

1. Place the pads – anterior-posterior (preferred) or anterior-lateral. The anterior electrode is placed left parasternal, the posterior electrode between the left scapula and the spine.
2. Select demand mode – the pacemaker fires only when the intrinsic rate falls below the set rate.
3. Set the rate – starting rate 60–80/min.
4. Gradually increase the current – starting at 0 mA, increase stepwise until electrical capture is achieved (each stimulus produces a QRS complex). Typical thresholds are 40–80 mA but can be considerably higher.
5. Verify capture – Don't just look at the ECG! Pacing artifacts can mimic true QRS complexes. Verify mechanical capture by:
   • Palpation of a peripheral pulse (femoral artery – thoracic muscle contractions make palpation at the radial or carotid artery unreliable)
   • Blood pressure measurement
   • Pulse oximetry waveform
6. Safety margin – once capture is achieved, increase the current by 10% above the threshold (safety margin).

Don't Forget Analgesia

Transcutaneous pacing is painful. The electrical impulses cause involuntary contractions of the thoracic and intercostal muscles. In conscious patients, adequate analgosedation is mandatory. Well-established options include:

• Midazolam 1–2 mg IV titrated (sedation)
• Fentanyl 25–50 µg IV titrated (analgesia)
• Alternatively: Ketamine in analgesic doses (0.25–0.5 mg/kg IV)

Titration is the keyword here – not too little (the patient suffers), not too much (respiratory depression, loss of consciousness without intubation readiness).

Common Pitfalls in Transcutaneous Pacing

• Absent mechanical capture despite apparent electrical capture – a pacing spike ≠ an effective heartbeat. Always check pulse and hemodynamics.
• Current set too low – especially in obese patients, COPD with hyperinflation, or pericardial effusion, very high energies may be required. Maximum current up to 200 mA is possible.
• Pads in incorrect position – with anterior-posterior placement, ensure the electrodes are not directly aligned but slightly offset.

Pharmacological Alternatives to Pacing

Epinephrine (Adrenaline)

Epinephrine is the preferred pharmacological alternative when transcutaneous pacing is not immediately available or as a bridging measure.

Dosing:

• 2–10 µg/min as a continuous intravenous infusion
• Titrate to heart rate and blood pressure

Practical preparation (example): 1 mg epinephrine (= 1 ampoule of 1 mg/ml) in 250 ml normal saline yields a concentration of 4 µg/ml. This allows precise dose titration using a syringe pump.

Epinephrine acts via β1 receptors to produce positive chronotropic and positive inotropic effects. It increases both heart rate and blood pressure simultaneously, which is desirable in hemodynamically unstable bradycardias.

Dopamine

Dopamine is the second pharmacological option in the ACLS algorithm.

Dosing:

• 5–20 µg/kg/min as a continuous intravenous infusion
• At lower doses (2–5 µg/kg/min), dopaminergic effects predominate; the chronotropic effect only emerges in the β-adrenergic dose range (5–10 µg/kg/min).

In practice, epinephrine is often preferred because it is more controllable and provides a more reliable chronotropic effect. Both agents are listed as equivalent options in the algorithm.

Isoproterenol (Isoprenaline)

Isoproterenol, a pure β-agonist, is mentioned in some European guidelines as an alternative for bradycardia. It is not primarily listed in the AHA algorithm but may be an option particularly for the denervated heart (post-transplant). Dosing: 1–5 µg/min IV.

Differential Diagnoses: Why Is the Heart Slow?

Workup of the underlying cause runs in parallel with acute therapy. A structured approach prevents treatable causes from being overlooked.

Cardiac Causes

• Sick sinus syndrome (sinus node dysfunction)
• AV blocks (first-degree, second-degree type 1 and type 2, third-degree)
• Acute myocardial infarction – especially inferior MI (RCA territory → sinus node and AV node)
• Myocarditis
• Postoperative bradycardia (after cardiac surgery)

Extracardiac Causes

• Medications – beta-blockers, calcium channel blockers (verapamil, diltiazem), digoxin, amiodarone, clonidine, cholinesterase inhibitors
• Hypothermia – below a core body temperature of 30°C, heart rate drops drastically
• Electrolyte disturbances – especially hyperkalemia
• Elevated intracranial pressure (Cushing reflex: bradycardia + hypertension + irregular breathing)
• Hypothyroidism
• Obstructive sleep apnea (vagally mediated)
• Reflex bradycardia – vasovagal reaction, oculocardiac reflex, carotid sinus massage

Special Attention: Drug-Induced Bradycardia

In cases of beta-blocker or calcium channel blocker toxicity, the bradycardia algorithm alone may not be sufficient. Specific antidotes and measures should be considered:

• Beta-blocker toxicity: High-dose glucagon (3–10 mg IV bolus, then 3–5 mg/h as infusion), high-dose insulin euglycemia therapy (HIE), lipid emulsion rescue
• Calcium channel blocker toxicity: Calcium chloride 10% (10–20 ml IV), HIE therapy, lipid emulsion rescue if indicated
• Digoxin toxicity: Digoxin-specific antibody fragments (Digoxin-Fab)

Decision Tree: Correctly Classifying AV Block

Correct classification of AV block is crucial for therapy planning:

AV Block Type	ECG Criteria	Atropine Response	Pacing Indication
First-degree	PR > 200 ms, all P waves conducted	Usually good	Rarely needed
Second-degree Type 1 (Wenckebach)	Progressive PR prolongation until a dropped beat	Usually good	Rarely needed
Second-degree Type 2 (Mobitz)	Constant PR interval with sudden dropped beat	Poor	Early
Third-degree (complete)	Complete AV dissociation	Variable to poor	Urgent

Remember: A narrow QRS complex in third-degree AV block suggests a junctional escape rhythm (suprahisian) – somewhat more stable. A wide QRS complex suggests a ventricular escape rhythm (infrahisian) – unstable, with risk of asystole.

Special Situation: Bradycardia and Cardiac Arrest

Not every bradycardia can be successfully treated. With progressive rate decline despite therapy or with wide, slow escape rhythms, deterioration into pulseless electrical activity (PEA) or asystole may be imminent. In this case, you seamlessly transition to the ACLS cardiac arrest algorithm:

• Begin CPR
• Epinephrine 1 mg IV every 3–5 minutes
• Search for and treat reversible causes (Hs and Ts)

Summary: Algorithm at a Glance

1. Identify bradycardia (HR < 50/min with symptoms)
2. Secure ABC, 12-lead ECG, monitoring, IV access
3. Symptomatic? → No: Observe → Yes: Continue
4. Atropine 0.5 mg IV (repeat every 3–5 min, max. 3 mg)
5. If atropine fails or infranodal block is present:
   • Transcutaneous pacing (rate 60–80/min, titrate current, verify capture, analgesia!)
   • Epinephrine 2–10 µg/min IV
   • Dopamine 5–20 µg/kg/min IV
6. Arrange transvenous pacemaker (definitive therapy)
7. In parallel: Treat reversible causes (medications, electrolytes, temperature, ischemia)

Practical Training

The bradycardia algorithm comes to life through hands-on practice – from rapid recognition of hemodynamic instability to correct atropine dosing to confident handling of transcutaneous pacing under stress. All of this is best trained in realistic simulation scenarios. In the ACLS Refresher Course by Simulation Tirol, you work through these scenarios, practice the algorithms in real time, and receive structured feedback. Because knowing the algorithm is one thing – executing it routinely in an emergency is another.